- Home
- Publications
-
Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Jeffrey R. Bishop, Fedra Najjar, Leah H. Rubin, Stephen J. Guter, Thomas Owley, Matthw W. Mosconi, Suma Jacob, Edwin H. Cook
- Title
- Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.
- Journal
- Pharmacogenetics and Genomics
- Year
- 2015
- Month
- November
- Volume
- 25
- Issue
- 11
- Page(s)
- pp. 548-554.
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Peer-Reviewed, Open Trial
- Keywords
- Adolescent / Secondary School Age, Adult, Antidepressants, Asperger Syndrome, Autism, Autistic Disorder, Child/Children, Escitalopram, Intervention, Irritability, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Pre-School / Toddlers, Primary / Elementary School Age, Selective Serotonin Reuptake Inhibitors
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.